Canine longevity drug advances toward FDA approvalMarch 4, 2025The FDA’s Center for Veterinary Medicine has accepted the Reasonable Expectation of Effectiveness (RXE) for LOY-002. Learn more about what this ‘milestone’ means in the pursuit of an FDA conditional approval.
SPONSORED CONTENTYour Parasite Protection Recommendation, SimplifiedManaging parasite prevention doesn’t have to be complicated. Discover a single solution that protects against multiple threats. + Learn More
$45M additional funding bolsters development of canine longevity drugMarch 25, 2024The latest financing round brings the total funds raised for the first FDA-approved dog lifespan extension drug to $125M